JP2015535839A5 - - Google Patents

Download PDF

Info

Publication number
JP2015535839A5
JP2015535839A5 JP2015533635A JP2015533635A JP2015535839A5 JP 2015535839 A5 JP2015535839 A5 JP 2015535839A5 JP 2015533635 A JP2015533635 A JP 2015533635A JP 2015533635 A JP2015533635 A JP 2015533635A JP 2015535839 A5 JP2015535839 A5 JP 2015535839A5
Authority
JP
Japan
Prior art keywords
alkyl
carboxylic acid
compound
amino
heteroarylalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015533635A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015535839A (ja
JP6298998B2 (ja
Filing date
Publication date
Priority claimed from EP12306196.2A external-priority patent/EP2712866A1/en
Application filed filed Critical
Publication of JP2015535839A publication Critical patent/JP2015535839A/ja
Publication of JP2015535839A5 publication Critical patent/JP2015535839A5/ja
Application granted granted Critical
Publication of JP6298998B2 publication Critical patent/JP6298998B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015533635A 2012-10-01 2013-10-01 ウイルス感染を治療するための1,2,4−トリアジン誘導体 Expired - Fee Related JP6298998B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12306196.2A EP2712866A1 (en) 2012-10-01 2012-10-01 1,2,4-triazine derivatives for the treatment of viral infections
EP12306196.2 2012-10-01
PCT/EP2013/070488 WO2014053516A1 (en) 2012-10-01 2013-10-01 1,2,4-triazine derivatives for the treatment of viral infections.

Publications (3)

Publication Number Publication Date
JP2015535839A JP2015535839A (ja) 2015-12-17
JP2015535839A5 true JP2015535839A5 (https=) 2016-11-10
JP6298998B2 JP6298998B2 (ja) 2018-03-28

Family

ID=46982496

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015533635A Expired - Fee Related JP6298998B2 (ja) 2012-10-01 2013-10-01 ウイルス感染を治療するための1,2,4−トリアジン誘導体

Country Status (21)

Country Link
US (1) US9416114B2 (https=)
EP (2) EP2712866A1 (https=)
JP (1) JP6298998B2 (https=)
KR (1) KR102138393B1 (https=)
CN (1) CN104812747B (https=)
AU (1) AU2013326579B2 (https=)
BR (1) BR112015007310B1 (https=)
CA (1) CA2886630C (https=)
CL (1) CL2015000787A1 (https=)
EA (1) EA026236B1 (https=)
ES (1) ES2616496T3 (https=)
IL (1) IL237871A (https=)
IN (1) IN2015DN03327A (https=)
MX (1) MX348229B (https=)
MY (1) MY182558A (https=)
NZ (1) NZ706354A (https=)
PH (1) PH12015500724A1 (https=)
SG (1) SG11201502522WA (https=)
UA (1) UA114644C2 (https=)
WO (1) WO2014053516A1 (https=)
ZA (1) ZA201502240B (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE055286T2 (hu) 2011-04-08 2021-11-29 Janssen Sciences Ireland Unlimited Co Pirimidinszármazékok vírusfertõzések kezelésére
RS57851B1 (sr) 2011-11-09 2018-12-31 Janssen Sciences Ireland Uc Purinski derivati za tretman viralnih infekcija
CA2874800C (en) 2012-07-13 2021-04-06 Janssen R&D Ireland Macrocyclic purines for the treatment of viral infections
LT2906563T (lt) 2012-10-10 2018-06-11 Janssen Sciences Ireland Uc Pirolo[3,2-d]pirimidino dariniai virusinių infekcijų ir kitų ligų gydymui
EP2925729B1 (en) 2012-11-16 2017-10-18 Janssen Sciences Ireland UC Heterocyclic substituted 2-amino-quinazoline derivatives for the treatment of viral infections
WO2014128189A1 (en) 2013-02-21 2014-08-28 Janssen R&D Ireland 2-aminopyrimidine derivatives for the treatment of viral infections
AU2014242954B2 (en) 2013-03-29 2018-03-15 Janssen Sciences Ireland Uc Macrocyclic deaza-purinones for the treatment of viral infections
SG11201509520QA (en) 2013-05-24 2015-12-30 Janssen Sciences Ireland Uc Pyridone derivatives for the treatment of viral infections and further diseases
BR112015032546B1 (pt) 2013-06-27 2022-05-17 Janssen Sciences Ireland Uc Derivados de pirrolo[3,2-d]pirimidina e composição farmacêutica que os compreende para o tratamento de infecções virais e outras doenças
KR102322425B1 (ko) 2013-07-30 2021-11-05 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 바이러스 감염의 치료를 위한 티에노[3,2-d]피리미딘 유도체
AU2017289418B2 (en) 2016-07-01 2021-06-03 Janssen Sciences Ireland Unlimited Company Dihydropyranopyrimidines for the treatment of viral infections
JP7274415B2 (ja) * 2016-09-29 2023-05-16 ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー ウイルス感染症および他の疾患を処置するためのピリミジンプロドラッグ
TW202415645A (zh) 2018-03-01 2024-04-16 愛爾蘭商健生科學愛爾蘭無限公司 2,4-二胺基喹唑啉衍生物及其醫學用途
JP7287708B2 (ja) 2019-02-08 2023-06-06 プロジェニア インコーポレイテッド Toll-like受容体7または8アゴニストとコレステロールの結合体およびその用途
JP7811014B2 (ja) 2020-03-02 2026-02-04 プロジェニア インコーポレイテッド 病原菌外壁成分基盤の生病原体模倣ナノ粒子及びその製造方法
JP2023536954A (ja) 2020-08-04 2023-08-30 プロジェニア インコーポレイテッド 活性化部位が一時的に不活性化したトール様受容体7または8作用薬と機能性薬物の結合体およびその用途
US20230355750A1 (en) 2020-08-04 2023-11-09 Progeneer Inc. Kinetically acting adjuvant ensemble
CN116322751A (zh) 2020-08-04 2023-06-23 蛋白科技先锋 包含能够动力学控制的佐剂的mRNA疫苗
WO2024151953A1 (en) * 2023-01-15 2024-07-18 Viradem Inc. Compounds and methods for treating diseases caused by sars-cov-2 and other coronaviruses

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2485531A1 (fr) * 1980-06-25 1981-12-31 Fabre Sa Pierre Nouveaux n-oxydes de diaryl-5,6 as triazines 1-2-4, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
ATE283855T1 (de) 1996-07-03 2004-12-15 Sumitomo Pharma Neue purinderivate
NZ504800A (en) 1997-11-28 2001-10-26 Sumitomo Pharma 6-Amino-9-benzyl-8-hydroxy-purine derivatives and interferon inducers, antiviral agents, anticancer agents and therapeutic agents for immunologic diseases thereof
ES2442857T3 (es) * 2004-08-10 2014-02-13 Janssen Pharmaceutica Nv Derivados de 1,2,4-triazin-6-ona inhibidores de VIH
EP1888587A1 (en) 2005-05-04 2008-02-20 Pfizer Limited 2-amido-6-amino-8-oxopurine derivatives as toll-like receptor modulators for the treatment of cancer and viral infections, such as hepatitis c
CA2619919C (en) * 2005-09-01 2014-04-01 F. Hoffmann-La Roche Ag Diaminopyrimidines as p2x3 and p2x2/3 modulators
RU2352565C1 (ru) * 2007-10-08 2009-04-20 Государственное образовательное учреждение высшего профессионального образования "Пермский государственный университет" 3-амино-6-ароилметил-5-гидрокси-1,2,4-триазины и способ их получения
PE20091236A1 (es) * 2007-11-22 2009-09-16 Astrazeneca Ab Derivados de pirimidina como immunomoduladores de tlr7
WO2012067269A1 (en) * 2010-11-19 2012-05-24 Dainippon Sumitomo Pharma Co., Ltd. Aminoalkoxyphenyl compounds and their use in the treatment of disease

Similar Documents

Publication Publication Date Title
JP2015535839A5 (https=)
HRP20200538T1 (hr) Derivati pirimidina za liječenje virusnih infekcija
SI2906563T1 (en) Derivatives of pyrrolo (3,2-d) pyrimidine for the treatment of viral infections and other diseases
PH12019502370A1 (en) Salt of an aminopyridine derivative compound, a crystalline form thereof, and a process for preparing the same
JP2015537020A5 (https=)
NZ627036A (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
HRP20180447T1 (hr) Derivati kinazolina za liječenje virusnih infekcija i drugih bolesti
JP2016530259A5 (https=)
JP2016519165A5 (https=)
EP3954679A3 (en) Amide compounds for the treatment of hiv infections
JP2016540742A5 (https=)
JP2017523225A5 (https=)
RU2014141579A (ru) Гетероциклические соединения в качестве ингибиторов бета-лактамаз
JP2014514360A5 (https=)
JP2016522172A5 (https=)
JP2017533968A5 (https=)
JP2014506907A5 (https=)
JP2015509535A5 (https=)
JP2016518305A5 (https=)
JP2015520140A5 (https=)
JP2011037841A5 (https=)
MX2015001571A (es) Compuestos de anillo en puente como inhibidores del virus de la hepatitis c (hcv) y sus aplicaciones farmaceuticas.
HRP20171720T1 (hr) Derivati pirolo [3,2-d] pirimidina za liječenje virusnih infekcija i drugih bolesti
JP2015535847A5 (https=)
JP2017517565A5 (https=)